409 related articles for article (PubMed ID: 30243142)
1. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
[TBL] [Abstract][Full Text] [Related]
2. Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.
Des Jarlais DC; Arasteh K; McKnight C; Feelemyer J; Perlman DC; Tross S
Drug Alcohol Depend; 2019 Nov; 204():107459. PubMed ID: 31521951
[TBL] [Abstract][Full Text] [Related]
3. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z
PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.
Jordan AE; Des Jarlais DC; Arasteh K; McKnight C; Nash D; Perlman DC
Drug Alcohol Depend; 2015 Jul; 152():194-200. PubMed ID: 25891230
[TBL] [Abstract][Full Text] [Related]
5. From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.
Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Tross S; Perlman DC; Campbell AN; Cooper HL; Hagan H
J Subst Abuse Treat; 2016 Dec; 71():48-53. PubMed ID: 27776677
[TBL] [Abstract][Full Text] [Related]
6. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.
Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khuê Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N;
Int J Drug Policy; 2016 Jun; 32():50-6. PubMed ID: 27006257
[TBL] [Abstract][Full Text] [Related]
7. Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Tross S; Perlman DC; Campbell AN; Hagan H; Cooper HL
Sex Transm Dis; 2017 Feb; 44(2):85-90. PubMed ID: 27898577
[TBL] [Abstract][Full Text] [Related]
8. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
9. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
[TBL] [Abstract][Full Text] [Related]
10. What happened to the HIV epidemic among non-injecting drug users in New York City?
Des Jarlais DC; Arasteh K; McKnight C; Feelemyer J; Campbell AN; Tross S; Cooper HL; Hagan H; Perlman DC
Addiction; 2017 Feb; 112(2):290-298. PubMed ID: 27613968
[TBL] [Abstract][Full Text] [Related]
11. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
[TBL] [Abstract][Full Text] [Related]
12. Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001-2005 and 2011-2015.
Des Jarlais DC; McKnight C; Feelemyer J; Arasteh K; Tross S; Campbell ANC; Cooper HLF; Perlman DC
Drug Alcohol Depend; 2018 Apr; 185():391-397. PubMed ID: 29549851
[TBL] [Abstract][Full Text] [Related]
13. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
[TBL] [Abstract][Full Text] [Related]
14. Field Testing the "Avoid the Needle" Intervention for Persons at Risk for Transitioning to Injecting Drug Use in Tallinn, Estonia and New York City, USA.
Jarlais DCD; McKnight C; Weng CA; Feelemyer J; Tross S; Raag M; Org G; Talu A; Uuskula A
AIDS Behav; 2023 Nov; 27(11):3767-3779. PubMed ID: 37249805
[TBL] [Abstract][Full Text] [Related]
15. Can intranasal drug use reduce HCV infection among injecting drug users?
Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Semaan S; Perlman DC
Drug Alcohol Depend; 2011 Dec; 119(3):201-6. PubMed ID: 21794991
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus risk among young people who inject drugs.
Mateu-Gelabert P; Sabounchi NS; Guarino H; Ciervo C; Joseph K; Eckhardt BJ; Fong C; Kapadia SN; Huang TTK
Front Public Health; 2022; 10():835836. PubMed ID: 35968435
[TBL] [Abstract][Full Text] [Related]
17. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
18. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
[TBL] [Abstract][Full Text] [Related]
19. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
[TBL] [Abstract][Full Text] [Related]
20. Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history.
Des Jarlais DC; McKnight C; Arasteh K; Feelemyer J; Ross Z; Cooper HLF
Harm Reduct J; 2019 Sep; 16(1):53. PubMed ID: 31477150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
